{
    "organizations": [],
    "uuid": "2eb92599a78b562a4ae318b5a2e458b62d0d232a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-zealand-reports-royalty-revenue-of/brief-zealand-reports-royalty-revenue-of-dkk-11-3-mln-for-q4-2017-idUSASM000J0I",
    "ord_in_thread": 0,
    "title": "BRIEF-Zealand Reports Royalty Revenue Of DKK 11.3 Mln For Q4 2017",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 7 (Reuters) - ZEALAND PHARMA A/S:\n* REG-ZEALAND REPORTS ROYALTY REVENUE FOR THE FOURTH QUARTER OF 2017\n* ZEALAND REPORTS ROYALTY REVENUE OF DKK 11.3 MILLION/USD 1.8 MILLION FOR Q4 2017\n* ‍IN Q4 SOLIQUA 100/33 SALES GREW 30% OVER PREVIOUS QUARTER​\n* ROYALTY REVENUE FOR 2017 AMOUNTED TO DKK 38.8 MILLION/USD 6.3 MILLION AN INCREASE OF 59% OVER PREVIOUS YEAR​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-07T14:55:00.000+02:00",
    "crawled": "2018-02-09T06:12:06.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "zealand",
        "pharma",
        "report",
        "royalty",
        "revenue",
        "fourth",
        "quarter",
        "zealand",
        "report",
        "royalty",
        "revenue",
        "dkk",
        "million",
        "q4",
        "q4",
        "soliqua",
        "sale",
        "grew",
        "previous",
        "royalty",
        "revenue",
        "amounted",
        "dkk",
        "million",
        "increase",
        "previous",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}